ClinicalTrials.gg
CompletedNCT07938229CAT-OCTUpdated Nov 16, 2026

Development of a Clinical Decision Support System for Cataract Surgery Planning Using Swept Source Optical Biometry

An observational study in Cataract, sponsored by Clínica de Oftalmología de Cali S.A. Completed at 1 site in Colombia. Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Clínica de Oftalmología de Cali S.A · Observational

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
499
Ages
40 Years and older
Sex
All
01

Study summary

This single-center, observational, analytical, ambispective study aims to develop and internally validate a clinical decision support system for cataract surgery planning using swept-source optical coherence tomography (SS-OCT) integrated into the ARGOS optical biometer.

The study will evaluate the ability of preoperative crystalline lens tomographic patterns (Types I-III) to predict surgical complexity and the surgical approach required during cataract extraction. Additionally, it will assess whether SS-OCT-derived information provides incremental predictive value beyond conventional clinical assessment using the Lens Opacities Classification System III (LOCS III).

Clinical, biometric, and surgical data will be analyzed to determine the predictive performance, reproducibility, and technical feasibility of the proposed classification system. The ultimate goal is to establish an objective, noninvasive, and reproducible tool to support personalized surgical planning and preoperative risk stratification in cataract surgery.

Read the detailed description

Background and Rationale

Cataract remains a leading cause of visual impairment and preventable blindness worldwide. Although advances in surgical techniques and technology have improved cataract surgery outcomes, predicting surgical complexity and selecting the most appropriate surgical approach remain important clinical challenges. Currently, preoperative assessment relies primarily on clinical examination and subjective grading systems, such as the Lens Opacities Classification System III (LOCS III), which may exhibit interobserver variability.

Swept-source optical coherence tomography (SS-OCT), integrated into optical biometers such as ARGOS (Alcon Laboratories, Inc.), provides noninvasive, high-resolution images of the crystalline lens and biometric measurements. These images may reveal morphological characteristics associated with lens opacity, nuclear density, and surgical complexity.

This study proposes the development and internal validation of a clinical decision support system based on the identification of specific crystalline lens tomographic patterns to improve preoperative risk stratification and support cataract surgery planning.

Study Design and Population

This is a single-center, observational, analytical, ambispective study conducted at Clínica de Oftalmología de Cali, Colombia. The study will include patients older than 40 years undergoing crystalline lens extraction who have undergone preoperative optical biometry using the ARGOS device, including SS-OCT imaging of the crystalline lens.

The ambispective design will incorporate retrospectively identified surgical cases and prospectively included patients. Surgical management will follow routine clinical practice, without experimental treatment assignment or modification of the surgical technique by the investigators.

Patients undergoing combined cataract surgery with glaucoma, corneal, or retinal procedures, those with a history of significant ocular trauma affecting anterior segment anatomy, and patients with ocular conditions preventing reliable tomographic image acquisition will be excluded.

A reference group of patients with clear crystalline lenses who underwent ARGOS biometry for indications other than cataract will be used exclusively to characterize the Type I tomographic pattern. These individuals will not be included in the statistical analysis.

Preoperative Assessment and Tomographic Classification

Preoperative evaluation will include demographic characteristics, visual acuity, LOCS III cataract grading, relevant ocular comorbidities, and biometric parameters obtained using ARGOS.

Crystalline lens SS-OCT images will be classified according to three predefined tomographic patterns (Types I, II, and III), based on lens reflectivity, intralenticular signal distribution, and the morphological characteristics of the anterior and posterior lens peaks.

Images will be independently assessed by trained observers blinded to the surgical technique and intraoperative outcomes. Disagreements will be resolved through consensus or third-observer adjudication. Interobserver and intraobserver reproducibility will be evaluated.

Study Outcomes

The primary outcome will be the need for a complex surgical approach during cataract extraction, defined using prespecified objective criteria derived from surgical records and, when available, surgical recordings.

Secondary outcomes will include the specific surgical technique performed, conversion from the initially planned approach, phacoemulsification energy parameters, intraoperative complications, and technical feasibility of SS-OCT image acquisition and interpretation.

Statistical Analysis and Internal Validation

The predictive performance of the proposed tomographic classification will be assessed using sensitivity, specificity, positive and negative predictive values, likelihood ratios, and overall classification accuracy, with 95% confidence intervals.

Multivariable logistic regression will be used to evaluate the association between SS-OCT patterns and surgical complexity. A conventional clinical prediction model based on LOCS III and prespecified clinical variables will be compared with an expanded model incorporating the SS-OCT tomographic classification.

Model discrimination will be evaluated using the area under the receiver operating characteristic curve (AUC-ROC), while calibration will be assessed by comparing predicted and observed outcomes. Internal validation will be performed using bootstrap resampling.

Expected Clinical Relevance

The study seeks to determine whether SS-OCT-derived crystalline lens patterns can provide clinically useful information beyond conventional cataract grading. If validated, this classification could support more objective preoperative assessment, improve identification of surgically complex cases, and facilitate individualized cataract surgery planning using information already available from routine optical biometry.

The proposed system is intended to complement, rather than replace, clinical judgment. Further external validation will be required before its implementation in routine clinical practice.

02

Conditions studied

  • Cataract

Browse trials for

Keywords

  • Cataract Surgery
  • Clinical Decision Support System
  • Surgical Planning
  • Swept-Source Optical Coherence Tomography
  • Biometry
03

In context

Cataract

1,632 studies on the registry are indexed under Cataract; 235 are open to participants now.

This study's enrollment of 499 is above the median of 90 across 476 observational studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Clínica de Oftalmología de Cali S.A is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

For the establishment of the reference group with clear crystalline lenses, patients who underwent optical biometry using the ARGOS device for indications other than cataract, such as myopia monitoring, will be included to characterize the Type I pattern. These patients were not included in the statistical analysis of the study.

The study population will consist of patients older than 40 years with an indication for crystalline lens extraction and preoperative biometry performed using ARGOS, including acquisition of SS-OCT images of the crystalline lens. Patients in whom both the preoperative tomographic pattern and the surgical outcome can be adequately determined will be eligible.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients older than 40 years undergoing crystalline lens extraction surgery.
  • Preoperative optical biometry performed using the ARGOS biometer, including swept-source optical coherence tomography (SS-OCT) imaging of the crystalline lens.
  • Availability of sufficient preoperative tomographic information and surgical records to determine both the lenticular tomographic pattern and the surgical outcome.

Exclusion criteria

Exclusion Criteria:

  • Patients undergoing combined cataract surgery with glaucoma, corneal, or retinal procedures.
  • Patients with a history of ocular trauma capable of significantly altering anterior segment anatomy.
  • Patients with ocular conditions that prevent the acquisition of reliable tomographic images using swept-source optical coherence tomography (SS-OCT).
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
499 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Cataract Surgery Patients

    Patients older than 40 years undergoing cataract surgery with preoperative swept-source optical coherence tomography (SS-OCT) imaging obtained using the ARGOS biometer. Lenticular tomographic patterns will be classified and evaluated for their ability to predict surgical complexity and the surgical approach required.

    Diagnostic Test: Swept-Source Optical Coherence Tomography (SS-OCT) Using ARGOS Biometer

Interventions

  • Diagnostic testSwept-Source Optical Coherence Tomography (SS-OCT) Using ARGOS Biometer

    Preoperative assessment of crystalline lens tomographic patterns using swept-source optical coherence tomography (SS-OCT) integrated into the ARGOS optical biometer. Images will be classified according to predefined lenticular patterns (Types I-III) to evaluate their predictive value for surgical complexity and surgical approach during cataract extraction.

    Also known as: ARGOS Biometer, ARGOS Swept-Source OCT, SS-OCT Optical Biometry

06

What researchers measure

Primary outcomes

  1. Predictive Performance of SS-OCT Lenticular Patterns for Surgical Complexity in Cataract Surgery

    Assessment of the ability of preoperative crystalline lens tomographic patterns (Types I-III), obtained using swept-source optical coherence tomography (SS-OCT) with the ARGOS biometer, to predict the need for a complex surgical approach during cataract extraction. Surgical complexity will be classified as conventional or complex according to predefined objective criteria derived from operative records. Predictive performance will be evaluated using sensitivity, specificity, positive and negative predictive values, likelihood ratios, and overall classification accuracy, with 95% confidence intervals.

    Time frame: 6 months

Secondary outcomes

  1. Incremental Predictive Value of SS-OCT Compared With LOCS III

    Evaluation of the additional predictive value of SS-OCT lenticular patterns beyond conventional clinical assessment using LOCS III. Predictive models will be compared in terms of discrimination, measured by the area under the receiver operating characteristic curve (AUC-ROC), and calibration.

    Time frame: 6 months

  2. Distribution of Surgical Techniques Across SS-OCT Lenticular Pattern Categories

    To determine the percentage of eyes undergoing each surgical technique within the preoperative lenticular pattern categories (I, II, and III), as classified using swept-source optical coherence tomography (SS-OCT) images obtained with the ARGOS optical biometer. Surgical techniques will be identified from operative records and categorized as phacoemulsification (divide and conquer, stop and chop, vertical chop, or horizontal chop), extracapsular cataract extraction, or manual small-incision cataract surgery (MSICS). The frequency distribution of surgical techniques will be compared across SS-OCT lenticular pattern categories using appropriate categorical statistical methods.

    Time frame: 6 months

  3. Cumulative Dissipated Energy During Phacoemulsification Across SS-OCT Lenticular Pattern Categories

    To quantify cumulative dissipated energy (CDE) during cataract surgery performed using phacoemulsification and describe its distribution across preoperative SS-OCT lenticular pattern categories (I, II, and III). CDE will be obtained from the phacoemulsification system records and expressed in the units reported by the device. Differences in CDE across lenticular pattern categories will be evaluated using statistical methods appropriate to the observed distribution of the data.

    Time frame: 6 months

  4. Interobserver and Intraobserver Reproducibility of SS-OCT Lenticular Pattern Classification

    Assessment of interobserver and intraobserver agreement in the classification of SS-OCT lenticular patterns (Types I-III), using percentage agreement and Cohen's kappa coefficient with 95% confidence intervals.

    Time frame: 6 months

  5. Incidence of Intraoperative Complications

    Assessment of the occurrence of intraoperative complications during cataract surgery and their association with preoperative SS-OCT lenticular patterns. Complication frequencies will be reported according to tomographic pattern classification.

    Time frame: 6 months

07

Study locations

1 site
  • Clínica de Oftalmología de Cali
    Cali, Valle del Cauca Department 760036, Colombia
08

References and documents

Publications

  • Day AC, Donachie PH, Sparrow JM, Johnston RL; Royal College of Ophthalmologists' National Ophthalmology Database. The Royal College of Ophthalmologists' National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications. Eye (Lond). 2015 Apr;29(4):552-60. doi: 10.1038/eye.2015.3. Epub 2015 Feb 13. PubMed 25679413 ↗
  • Reifeltshammer SA, Khalil H, Hoftberger T, Laubichler P, Pomberger L, Waser K, Bolz M, Hirnschall N. Evaluation of the crystalline lens diameter using swept-source optical coherence tomography. BMJ Open Ophthalmol. 2026 Aug 20;11(3):e002819. doi: 10.1136/bmjophth-2026-002819. PubMed 42624621 ↗
  • GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1. PubMed 33275949 ↗
  • Angmo D, Nongpiur ME, Sharma R, Sidhu T, Sihota R, Dada T. Clinical utility of anterior segment swept-source optical coherence tomography in glaucoma. Oman J Ophthalmol. 2016 Jan-Apr;9(1):3-10. doi: 10.4103/0974-620X.176093. PubMed 27013821 ↗
  • Hung KC, Ho TC, Lin PJ. Refractive outcomes after cataract surgery using swept-source OCT biometry and image-guided toric IOL alignment: a prospective comparative study in normal versus long axial length eyes. Sci Rep. 2026 Mar 2;16(1):11566. doi: 10.1038/s41598-026-41920-6. PubMed 41771979 ↗
  • Nguyen P, Chopra V. Applications of optical coherence tomography in cataract surgery. Curr Opin Ophthalmol. 2013 Jan;24(1):47-52. doi: 10.1097/ICU.0b013e32835aee7b. PubMed 23197267 ↗
  • Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D, Wu SY. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993 Jun;111(6):831-6. doi: 10.1001/archopht.1993.01090060119035. PubMed 8512486 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Clinical study report

Time frame: In 6 months

Access criteria: Restricted access by request

Data sharing details ↗ · www.visionsana.com

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2026 to primary completion in Oct 2026, 5 months.

Of 168 non-industry observational studies under Cataract, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 30. This study's 5 months is below that.

Counting every sponsor, half of 235 studies reached it within 16 months; a quarter within 9 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 20, 2026
First posted
Nov 16, 2026
StartActual
May 1, 2026
Primary completionActual
Oct 19, 2026
CompletionActual
Oct 19, 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07938229
Lead sponsor
Clínica de Oftalmología de Cali S.A
Responsible party
Sponsor
First posted
Nov 16, 2026
Start date
May 1, 2026
Primary completion
Oct 19, 2026
Completion
Oct 19, 2026
Last update
Nov 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion